ElevateBio is powering transformative cell and gene therapies today and for many decades to come.

Elevate right from the start.

We provide the enabling technologies, capabilities, and environment to innovate and accelerate the development of life-saving therapies.

Advancing technology

We have built a leading suite of next-generation enabling technologies in gene editing, induced pluripotent stem cells (iPSCs), and cell, protein, and vector engineering. Each one of these technologies is unique and highly differentiated on its own and integration of all in one company enables us to discover, develop, manufacture and commercialize an unprecedented broad spectrum of cell and gene therapies and regenerative medicines.

Pioneering science

We're pioneering new science to develop next-generation cell and gene therapies and regenerative medicines. We offer pioneering technologies, end-to-end capabilities, and our state-of-the-art facility to accelerate innovation.

BaseCamp provides a home for scientific founders to elevate scientific visions.

BaseCamp is a dedicated cell and gene therapy process innovation, process science, and manufacturing center that addresses the primary obstacles in cell and gene therapy and regenerative medicine.

Biotech the way it ought to be.

Integrating the smartest people, cutting-edge technologies, and the right kind of capital to to rewrite genes, regenerate cells, and redefine manufacturing right from the start.

Our Story

Together with scientific innovators and our strategic partners, we are rapidly building a diverse portfolio of companies.  


& Media

Stay up-to-date with news from across the ElevateBio ecosystem.

Press Releases

ElevateBio Announces Jill M. Mooney, Ph.D., Joins as Senior Vice President of Research and Development

June 2, 2022
Read moreRead more

ElevateBio Announces Presentation on Lentiviral Vector Platform at the American Society of Gene and Cell Therapy (ASGCT) Annual Meeting

May 4, 2022
Read moreRead more

ElevateBio Announces Andrew Sandford Joins as President of ElevateBio BaseCamp

January 19, 2022
Read moreRead more

ElevateBio to Present at the 40th Annual J.P. Morgan Healthcare Conference

January 6, 2022
Read moreRead more

ElevateBio Announces Issuance of U.S. Patent Providing Protection for RNA-Guided Nucleases Identified through its Life Edit Gene Editing Platform

November 15, 2021
Read moreRead more

ElevateBio Supercharges Gene Editing and Therapeutic Product Development Capabilities Through Acquisition of Life Edit Therapeutics

October 27, 2021
Read moreRead more

Boston Children’s Hospital and ElevateBio Announce Five-Year Cell and Gene Therapy Collaboration

June 29, 2021
Read moreRead more

ElevateBio Announces Margo Roberts, Ph.D. Joins as Scientific Advisor for Company’s Immunotherapy Platform Expansion

June 10, 2021
Read moreRead more

ElevateBio’s BaseCamp Selected as the 2021 Facility of the Year Award Category Winner for Operational Excellence by the International Society for Pharmaceutical Engineering

April 27, 2021
Read moreRead more

ElevateBio Announces Chief Scientific Officer of Regenerative Medicine, Melissa Carpenter, PhD, Elected to the International Society for Stem Cell Research Board of Directors

March 18, 2021
Read moreRead more

ElevateBio Scales Disruptive Cell and Gene Therapy Business Model with $525 Million Series C Financing

March 15, 2021
Read moreRead more